About Fermentalg
Fermentalg is a company based in Libourne (France) founded in 2005. Fermentalg has raised $30.3 million across 5 funding rounds from investors including Bpifrance, NextStage AM and Galia Gestion. The company has 64 employees as of December 31, 2024. Fermentalg offers products and services including Vegan Omega 3, Natural Colors, Natural Antioxidants, Proteins for Aquafeed, and Proteins for Petfood. Fermentalg operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Libourne, France
- Employees 64 as on 31 Dec, 2024
- Stage Public
-
Sectors
HealthcareAgriculture Environment
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Fermentalg Sa
-
Annual Revenue
$11.95 M (USD)183.32as on Dec 31, 2024
-
Net Profit
-$13.38 M (USD)8.99as on Dec 31, 2024
-
EBITDA
-$8.52 M (USD)12.79as on Dec 31, 2024
-
Total Equity Funding
$30.3 M (USD)
in 5 rounds
-
Latest Funding Round
Not available
-
Investors
Bpifrance
& 9 more
-
Employee Count
64
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Fermentalg
Fermentalg is a publicly listed company on the EURONEXT with ticker symbol ALGAE in France, operating in the Consumer non-durables sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Fermentalg
Fermentalg offers a comprehensive portfolio of products and services, including Vegan Omega 3, Natural Colors, Natural Antioxidants, Proteins for Aquafeed, and Proteins for Petfood.
Algae-derived omega 3 for vegan dietary and health needs.
Pigments from microalgae for natural food coloring applications.
Antioxidants sourced from algae for preservation and wellness.
Proteins for sustainable fish and aquaculture feed options.
Proteins for high-quality petfood and animal health products.
People of Fermentalg
Unlock access to complete
Funding Insights of Fermentalg
Fermentalg has successfully raised a total of $30.3M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Fermentalg
Fermentalg has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Bpifrance, NextStage AM and Galia Gestion.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
NextStage AM is recognized as a pioneer in capital development.
|
Locked | Locked | Locked | |
|
Galia Gestion is engaged in private equity investments in southwestern France.
|
Locked | Locked | Locked | |
|
Smalt Capital is engaged in capital investment and renewable energy financing.
|
Locked | Locked | Locked |
Investor details for Fermentalg
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fermentalg
Investment portfolio details for Fermentalg
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Fermentalg
Detailed financials for Fermentalg
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fermentalg Comparisons
Peer comparison for Fermentalg
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fermentalg
Fermentalg operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Fermentalg
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fermentalg
Complete news archive for Fermentalg
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fermentalg
Fermentalg was founded in 2005 and raised its 1st funding round 6 years after it was founded.
Fermentalg is headquartered in Libourne, France. It is registered at Libourne, Nouvelle-aquitaine, France.
Fermentalg is a funded company, having raised a total of $30.3M across 5 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Fermentalg is 64.
Annual revenue of Fermentalg is $11.95M as on Dec 31, 2024.
Fermentalg was founded in 2005 in Libourne, France, within the biotechnology sector focused on microalgae cultivation. Biomass is produced through proprietary fermentation processes for applications in animal feed, human nutrition, and energy production. Twenty-six patents have been filed for these methods, and operations include over 30 fermenters with capacities ranging from 1 to 750 liters.
Fermentalg's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Fermentalg offers Vegan Omega 3, Natural Colors, Natural Antioxidants, Proteins for Aquafeed, and Proteins for Petfood.
Yes, Fermentalg is publicly traded on EURONEXT under the ticker symbol ALGAE.
Fermentalg has 10 investors. Key investors include Bpifrance, NextStage AM, Galia Gestion, Smalt Capital, and Sofiproteol.
The ticker symbol of Fermentalg is ALGAE on EURONEXT.